157 related articles for article (PubMed ID: 24739903)
1. Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.
Prickett TD; Zerlanko BJ; Hill VK; Gartner JJ; Qutob N; Jiang J; Simaan M; Wunderlich J; Gutkind JS; Rosenberg SA; Samuels Y
J Invest Dermatol; 2014 Sep; 134(9):2390-2398. PubMed ID: 24739903
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Functional Analysis of GRIN2A in Tumor Samples.
Prickett TD; Gartner JJ; Samuels Y
Methods Mol Biol; 2017; 1677():93-116. PubMed ID: 28986867
[TBL] [Abstract][Full Text] [Related]
3. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate.
D'mello SA; Joseph WR; Green TN; Leung EY; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Cell Calcium; 2016 Dec; 60(6):384-395. PubMed ID: 27659111
[TBL] [Abstract][Full Text] [Related]
4. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
[TBL] [Abstract][Full Text] [Related]
5. NR1 and NR3B Composed Intranuclear
Hajdú T; Juhász T; Szűcs-Somogyi C; Rácz K; Zákány R
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966365
[TBL] [Abstract][Full Text] [Related]
6. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival.
D'mello SA; Flanagan JU; Green TN; Leung EY; Askarian-Amiri ME; Joseph WR; McCrystal MR; Isaacs RJ; Shaw JH; Furneaux CE; During MJ; Finlay GJ; Baguley BC; Kalev-Zylinska ML
Front Oncol; 2014 Jan; 3():333. PubMed ID: 24455489
[TBL] [Abstract][Full Text] [Related]
7. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
[TBL] [Abstract][Full Text] [Related]
8. Loss of Grin2a causes a transient delay in the electrophysiological maturation of hippocampal parvalbumin interneurons.
Camp CR; Vlachos A; Klöckner C; Krey I; Banke TG; Shariatzadeh N; Ruggiero SM; Galer P; Park KL; Caccavano A; Kimmel S; Yuan X; Yuan H; Helbig I; Benke TA; Lemke JR; Pelkey KA; McBain CJ; Traynelis SF
Commun Biol; 2023 Sep; 6(1):952. PubMed ID: 37723282
[TBL] [Abstract][Full Text] [Related]
9. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin.
Prickett TD; Zerlanko B; Gartner JJ; Parker SCJ; Dutton-Regester K; Lin JC; Teer JK; Wei X; Jiang J; Nisc Comparative Sequencing Program ; Chen G; Davies MA; Gershenwald JE; Robinson W; Robinson S; Hayward NK; Rosenberg SA; Margulies EH; Samuels Y
J Invest Dermatol; 2014 Feb; 134(2):452-460. PubMed ID: 24008424
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
Tang W; Liu D; Traynelis SF; Yuan H
Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
[TBL] [Abstract][Full Text] [Related]
12. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
13. Blocking glutamate-mediated signalling inhibits human melanoma growth and migration.
Song Z; He CD; Liu J; Sun C; Lu P; Li L; Gao L; Zhang Y; Xu Y; Shan L; Liu Y; Zou W; Zhang Y; Gao H; Gao W
Exp Dermatol; 2012 Dec; 21(12):926-31. PubMed ID: 23171453
[TBL] [Abstract][Full Text] [Related]
14. Two patients with a GRIN2A mutation and childhood-onset epilepsy.
DeVries SP; Patel AD
Pediatr Neurol; 2013 Dec; 49(6):482-5. PubMed ID: 24125812
[TBL] [Abstract][Full Text] [Related]
15. Paradigmatic De Novo
Santos-Gómez A; Miguez-Cabello F; Juliá-Palacios N; García-Navas D; Soto-Insuga V; García-Peñas JJ; Fuentes P; Ibáñez-Micó S; Cuesta L; Cancho R; Andreo-Lillo P; Gutiérrez-Aguilar G; Alonso-Luengo O; Málaga I; Hedrera-Fernández A; García-Cazorla À; Soto D; Olivella M; Altafaj X
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884460
[TBL] [Abstract][Full Text] [Related]
16. Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function.
Santos-Gómez A; Miguez-Cabello F; García-Recio A; Locubiche-Serra S; García-Díaz R; Soto-Insuga V; Guerrero-López R; Juliá-Palacios N; Ciruela F; García-Cazorla À; Soto D; Olivella M; Altafaj X
Hum Mol Genet; 2021 Feb; 29(24):3859-3871. PubMed ID: 33043365
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
Wei X; Walia V; Lin JC; Teer JK; Prickett TD; Gartner J; Davis S; ; Stemke-Hale K; Davies MA; Gershenwald JE; Robinson W; Robinson S; Rosenberg SA; Samuels Y
Nat Genet; 2011 May; 43(5):442-6. PubMed ID: 21499247
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
19. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
20. GRIN2A polymorphisms and expression levels are associated with lead-induced neurotoxicity.
Wu Y; Wang Y; Wang M; Sun N; Li C
Toxicol Ind Health; 2017 Apr; 33(4):332-339. PubMed ID: 27230353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
